baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Morgan Stanley Knock-Out GRF/ DE000MG7XE98 /

10/14/2024 5:12:31 PM	Chg.-	Bid8:41:23 AM	Ask8:41:23 AM	Underlying	Strike price	Expiration date	Option type
2.18EUR	-	2.11 Bid Size: 1,500	- Ask Size: -	GRIFOLS	7.6306 EUR	12/31/2078	Call

GlobeNewswire 7/31 GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HB...

GlobeNewswire 7/29 Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strength...

TeleTrader 7/8 Grifols family, Brookfield consider €5.5B takeover bid for Grifols

GlobeNewswire 7/1 Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years

Newsfile Corp 6/27 GRFS SHAREHOLDER ALERT: Johnson Fistel Announces Class Action Investigation of Grifols, S.A. for Pot...

GlobeNewswire 6/18 Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group

GlobeNewswire 6/17 Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immu...

GlobeNewswire 5/20 GigaGen Doses First Patient in Phase 1 Trial of Anti-CTLA-4 Oncology Drug Candidate GIGA-564 in Adva...

GlobeNewswire 4/18 Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...

GlobeNewswire 4/4 Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...

GlobeNewswire 3/31 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...

GlobeNewswire 3/29 Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...

GlobeNewswire 3/25 Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...

GlobeNewswire 3/23 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...

GlobeNewswire 3/22 Johnson Fistel, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investig...

GlobeNewswire 3/20 Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...

GlobeNewswire 3/15 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...

GlobeNewswire 3/1 GRFS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Grifols S.A. (NASDAQ: GRFS) ...

GlobeNewswire 2/14 Grifols announces positive topline phase 3 fibrinogen clinical trial results

GlobeNewswire 2/12 Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman

GlobeNewswire 2/11 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...

GlobeNewswire 2/8 Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman

GlobeNewswire 2/2 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...

GlobeNewswire 2/2 Grifols S.A.: Company Investigated by the Portnoy Law Firm

GlobeNewswire 2/1 Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman

Morgan Stanley Knock-Out GRF/ DE000MG7XE98 /

If you wish to receive reply to your feedback, please provide your email address.